Literature DB >> 11120672

The iterative two-stage population approach to IVGTT minimal modeling: improved precision with reduced sampling. Intravenous glucose tolerance test.

P Vicini1, C Cobelli.   

Abstract

The minimal model method is widely used to estimate glucose effectiveness (S(G)) and insulin sensitivity (S(I)) from intravenous glucose tolerance test (IVGTT) data. In the standard protocol (sIVGTT, 0.33 g/kg glucose bolus given at time 0), which allows the simultaneous assessment of beta-cell function, the precision of the individualized estimates often degrades and particularly so in the presence of reduced sampling schedules. Here, we investigated the use of a population approach, the iterative two-stage (ITS) approach, to analyze 16 sIVGTTs in healthy subjects and to obtain refined estimates of S(G) and S(I) in the population and in the individual subjects. The ITS is based on calculation of the population mean and standard deviation of the parameters at each iteration and then use of them as prior information for the individual analyses. Theoretically, the use of a prior in the ITS should improve the precision of the individual estimates. The customary approach (standard two stage, STS), where modeling is performed separately for each individual subject, does not take the population knowledge into account. We used both frequent (FSS, 30 samples) and (quasi-optimally) reduced (RSS, 14 samples) sampling schedules. For the FSS, STS gave estimates (mean +/- SD) for S(G) = 2.66 +/- 1.09 x 10(-2). min(-1) and S(I) = 6.46 +/- 6.99 10(-4). min(-1). microU(-1). ml, with an average precision of 51 (range 5-176) and 33% (3-91), respectively. RSS radically worsened the precision of both S(G) and S(I). However, RSS and ITS gave S(G) = 2.59 +/- 0.73 and S(I) = 6.06 +/- 7.28, with an average precision of 23 (12-42) and 27% (), respectively. In conclusion, population minimal modeling of sIVGTT data improves the precision of individual estimates of glucose effectiveness and insulin sensitivity, as the theory predicts, and, even with reduced sampling, the improvement is substantial.

Entities:  

Mesh:

Year:  2001        PMID: 11120672     DOI: 10.1152/ajpendo.2001.280.1.E179

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  5 in total

1.  Analysis of intravenous glucose tolerance test data using parametric and nonparametric modeling: application to a population at risk for diabetes.

Authors:  Vasilis Z Marmarelis; Dae C Shin; Yaping Zhang; Alexandra Kautzky-Willer; Giovanni Pacini; David Z D'Argenio
Journal:  J Diabetes Sci Technol       Date:  2013-07-01

2.  Optimization of the intravenous glucose tolerance test in T2DM patients using optimal experimental design.

Authors:  Hanna E Silber; Joakim Nyberg; Andrew C Hooker; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-06-25       Impact factor: 2.745

3.  IVGTT glucose minimal model covariate selection by nonlinear mixed-effects approach.

Authors:  Paolo Denti; Alessandra Bertoldo; Paolo Vicini; Claudio Cobelli
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-01-26       Impact factor: 4.310

4.  Measurement delay associated with the Guardian RT continuous glucose monitoring system.

Authors:  C Wei; D J Lunn; C L Acerini; J M Allen; A M Larsen; M E Wilinska; D B Dunger; R Hovorka
Journal:  Diabet Med       Date:  2010-01       Impact factor: 4.359

5.  Modeling Between-Subject Variability in Subcutaneous Absorption of a Fast-Acting Insulin Analogue by a Nonlinear Mixed Effects Approach.

Authors:  Edoardo Faggionato; Michele Schiavon; Chiara Dalla Man
Journal:  Metabolites       Date:  2021-04-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.